BACKGROUND: The aim was to examine whether excess weight is associated with coronary artery calcium (CAC), independent of metabolic parameters in adults with type 1 diabetes (T1D). METHODS: Subjects between 19 and 56 years of age with T1D (n=621) from the Coronary Artery Calcification in Type 1 Diabetes study were classified as abnormal on four metabolic parameters: blood pressure ≥130/85 mm Hg or on antihypertensive treatment; high-density lipoprotein-cholesterol of <40 mg/dL for men or <50 mg/dL for women; triglycerides of ≥150 mg/dL; or C-reactive protein of ≥3 μg/mL. Study participants with two or more abnormal parameters were classified as metabolically abnormal. Weight categories by body mass index were normal (<25 kg/m(2)), overweight (25 to <30 kg/m(2)), and obese (≥30 kg/m(2)). CAC was measured at two visits 6.0±0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥2.5 mm(3) or development of clinical coronary artery disease. RESULTS: Among subjects with T1D, 48% of normal, 61% of overweight, and 73% of obese participants were classified as metabolically abnormal (P<0.0001). Overweight and obesity were independently associated with presence of CAC, independent of presence of metabolically abnormal. Obesity but not overweight was associated with CAC progression, independent of the other cardiovascular risk factors. CONCLUSIONS: Although obesity is known to increase cardiovascular disease risk through inducing metabolic abnormalities such as dyslipidemia, hypertension, and inflammation, it is also a strong predictor of subclinical atherosclerosis progression in adults with T1D independent of these factors.
BACKGROUND: The aim was to examine whether excess weight is associated with coronary artery calcium (CAC), independent of metabolic parameters in adults with type 1 diabetes (T1D). METHODS: Subjects between 19 and 56 years of age with T1D (n=621) from the Coronary Artery Calcification in Type 1 Diabetes study were classified as abnormal on four metabolic parameters: blood pressure ≥130/85 mm Hg or on antihypertensive treatment; high-density lipoprotein-cholesterol of <40 mg/dL for men or <50 mg/dL for women; triglycerides of ≥150 mg/dL; or C-reactive protein of ≥3 μg/mL. Study participants with two or more abnormal parameters were classified as metabolically abnormal. Weight categories by body mass index were normal (<25 kg/m(2)), overweight (25 to <30 kg/m(2)), and obese (≥30 kg/m(2)). CAC was measured at two visits 6.0±0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥2.5 mm(3) or development of clinical coronary artery disease. RESULTS: Among subjects with T1D, 48% of normal, 61% of overweight, and 73% of obeseparticipants were classified as metabolically abnormal (P<0.0001). Overweight and obesity were independently associated with presence of CAC, independent of presence of metabolically abnormal. Obesity but not overweight was associated with CAC progression, independent of the other cardiovascular risk factors. CONCLUSIONS: Although obesity is known to increase cardiovascular disease risk through inducing metabolic abnormalities such as dyslipidemia, hypertension, and inflammation, it is also a strong predictor of subclinical atherosclerosis progression in adults with T1D independent of these factors.
Authors: Debra A Schaumberg; Robert J Glynn; Alicia J Jenkins; Timothy J Lyons; Nader Rifai; JoAnn E Manson; Paul M Ridker; David M Nathan Journal: Circulation Date: 2005-05-02 Impact factor: 29.690
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: Jonathan Q Purnell; Barbara H Braffett; Bernard Zinman; Rose A Gubitosi-Klug; William Sivitz; John P Bantle; Georgia Ziegler; Patricia A Cleary; John D Brunzell Journal: Diabetes Care Date: 2017-12 Impact factor: 19.112
Authors: Teresa Buckner; Baohai Shao; Robert H Eckel; Jay W Heinecke; Karin E Bornfeldt; Janet Snell-Bergeon Journal: J Clin Lipidol Date: 2020-10-31 Impact factor: 5.365
Authors: Petter Bjornstad; Janet K Snell-Bergeon; Marian Rewers; Diana Jalal; Michel B Chonchol; Richard J Johnson; David M Maahs Journal: Diabetes Care Date: 2013-09-11 Impact factor: 19.112